GetReal Conference 2024: Insights from Session 6 – envisioning the convergence of HTA and regulatory decision-making

During Session 6 of the GetReal Institute’s 2024 Annual Conference, Shahid Hanif welcomed Patrice Verpillat (European Medicines Agency’s [EMA], The Netherlands) and Niklas Hedberg (Dental and Pharmaceuticals Benefits Agency [TLV], Sweden) to provide their perspectives on the vision for the future if we accelerate the convergence of regulatory and HTA. Strengthening regulator–HTA collaboration  Patrice Verpillat kicked off the session by discussing ways to enhance the collaboration between regulators and health technology assessment (HTA) bodies. He highlighted that while their roles are distinct, they are complementary, noting that regulators determine efficacy through randomized controlled trials (RCTs) against a placebo, whereas HTA...